Manik Chhabra1, Amit Sharma1, Kumar Rathore Ajay2, Mahendra Singh Rathore3. 1. Department of Pharmacy Practice, ISF College of Pharmacy , Moga , India. 2. Department of Pharmacy, Government Pharmacy Institute , Patna , India. 3. Department of Pharmacy Practice, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University) , Ambala , India.
Abstract
Introduction: Objectives of this study were to assess risk factors, cost of treatment, and therapy outcomes in stroke patients. Methods: This cross-sectional study was conducted in 130 patients of either sex at a government tertiary care hospital of India. Relevant information was collected from available records and through patient interview after permission from the ethics committee. National Institute of Health Stroke Score (NIHSS) was used to assess therapy outcome. Analysis of variance and the students t-test were applied appropriately where needed. Results: Higher body mass index, sedentary lifestyle, tobacco use, and elevated systolic blood pressure were observed as risk factors in participants. The mean cost of stroke treatment observed at this hospital was Indian Rupee 17,934.71 (€ 218.70; USD 267.67). The direct medical cost was the principal component in stroke treatment that ranged from 6% to 27% of the average six-month salary of patients in different socioeconomic classes. A significant improvement (p < 0.05) in health outcome (NIHSS Score) was observed in participants after treatment. Conclusion: The data on the cost of stroke treatment from this study may be used for further pharmacoeconomic studies.
Introduction: Objectives of this study were to assess risk factors, cost of treatment, and therapy outcomes in strokepatients. Methods: This cross-sectional study was conducted in 130 patients of either sex at a government tertiary care hospital of India. Relevant information was collected from available records and through patient interview after permission from the ethics committee. National Institute of Health Stroke Score (NIHSS) was used to assess therapy outcome. Analysis of variance and the students t-test were applied appropriately where needed. Results: Higher body mass index, sedentary lifestyle, tobacco use, and elevated systolic blood pressure were observed as risk factors in participants. The mean cost of stroke treatment observed at this hospital was Indian Rupee 17,934.71 (€ 218.70; USD 267.67). The direct medical cost was the principal component in stroke treatment that ranged from 6% to 27% of the average six-month salary of patients in different socioeconomic classes. A significant improvement (p < 0.05) in health outcome (NIHSS Score) was observed in participants after treatment. Conclusion: The data on the cost of stroke treatment from this study may be used for further pharmacoeconomic studies.
Entities:
Keywords:
NIHSS; Stroke; cost of illness; risk factors; therapy outcome